EMAIL THIS PAGE TO A FRIEND

Oncotarget

CLDN3 inhibits cancer aggressiveness via Wnt-EMT signaling and is a potential prognostic biomarker for hepatocellular carcinoma.


PMID 25277196

Abstract

We're sorry this abstract is currently not available.